Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study

MeSH terms

• Aged
• Arterial Occlusive Diseases / chemically induced*
• Arterial Occlusive Diseases / mortality
• Disease-Free Survival
• Female
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
• Male
• Middle Aged
• Peripheral Arterial Disease / chemically induced*
• Peripheral Arterial Disease / mortality
• Pyrimidines / administration & dosage
• Pyrimidines / adverse effects*
• Retrospective Studies
• Survival Rate